PLA2R antibody levels and clinical outcome in patients with membranous nephropathy and non-nephrotic range proteinuria under treatment with inhibitors of the renin-angiotensin system.
about
Antiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous NephropathyMembranous Nephropathy: Quantifying Remission Duration on Outcome.Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years.Membranous Nephropathy: A Journey From Bench to BedsideAutoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy.Biomarkers to detect membranous nephropathy in Chinese patients.Membranous glomerulonephritis: histological and serological features to differentiate cancer-related and non-related forms.Primary Membranous Nephropathy.Anti-phospholipase A2 receptor antibody levels at diagnosis predicts spontaneous remission of idiopathic membranous nephropathy.A Proposal for a Serology-Based Approach to Membranous Nephropathy.Membranous nephropathy-one morphologic pattern with different diseases.Treatment of membranous nephropathy: time for a paradigm shift.Low-dose rituximab is poorly effective in patients with primary membranous nephropathy.Recent Progress in Deciphering the Etiopathogenesis of Primary Membranous Nephropathy.Treatment of primary membranous nephropathy: where are we now?The clinicopathological features of patients with membranous nephropathy.The Most N-Terminal Region of THSD7A Is the Predominant Target for Autoimmunity in THSD7A-Associated Membranous Nephropathy.The Role of PLA2R Antibody in Treatment of Membranous Nephropathy.Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy.Anti-phospholipase A2 receptor antibody as a prognostic marker in patients with primary membranous nephropathy
P2860
Q27023372-85F16314-EAFA-43FC-BD05-D1491C31302EQ36167127-AD4BB438-7C5C-489A-97D6-D04AF7C7F84EQ36296621-C176F090-5EB1-4654-9CD7-5A06A84F76DDQ37038576-60C021A2-D755-4D7E-810E-14CE44801D96Q37042246-831AA36B-B08B-4EE1-A7C2-8A120396F72AQ37708722-47F00F58-A83C-4B89-B3FE-8519D9D3106FQ38711526-F194B009-1BED-497A-9D32-EB54C9FEA4D8Q38760741-521C1401-D5FF-4F69-A201-BDC2A0E7C456Q38843422-0F2E38C7-A6CC-4678-A033-0B565A638468Q38989854-A288C230-2602-4009-83AF-8DE440488689Q39337229-1C2D4511-FD6F-4782-82C6-35DC1F55C692Q39410091-1FE96DE7-C961-4FDC-B222-1454284C3E18Q40663445-C56C703A-6A7D-4C22-9AC8-3BEEB534B939Q41622450-0A0179A6-5DDB-4123-BA53-5EE944503717Q47850601-9D5A6303-78A1-4DC2-BBDC-2642D60BBF3EQ49220788-54780204-2720-482C-BA38-8ED1ED3A8B88Q52349819-D72316AC-CF8B-4318-942E-5FD7DDD22E56Q55222782-FA31D0D3-4B7E-492C-8649-7D540E572C42Q55243742-D361BBDC-052E-4985-8234-70E36CBAB3EEQ58795388-549EB205-FA88-4246-AF65-86667EA89065
P2860
PLA2R antibody levels and clinical outcome in patients with membranous nephropathy and non-nephrotic range proteinuria under treatment with inhibitors of the renin-angiotensin system.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
PLA2R antibody levels and clin ...... the renin-angiotensin system.
@ast
PLA2R antibody levels and clin ...... the renin-angiotensin system.
@en
PLA2R antibody levels and clin ...... the renin-angiotensin system.
@nl
type
label
PLA2R antibody levels and clin ...... the renin-angiotensin system.
@ast
PLA2R antibody levels and clin ...... the renin-angiotensin system.
@en
PLA2R antibody levels and clin ...... the renin-angiotensin system.
@nl
prefLabel
PLA2R antibody levels and clin ...... the renin-angiotensin system.
@ast
PLA2R antibody levels and clin ...... the renin-angiotensin system.
@en
PLA2R antibody levels and clin ...... the renin-angiotensin system.
@nl
P2093
P2860
P1433
P1476
PLA2R antibody levels and clin ...... the renin-angiotensin system.
@en
P2093
Elion Hoxha
Hans Pinnschmidt
Rolf A K Stahl
Ulf Panzer
P2860
P304
P356
10.1371/JOURNAL.PONE.0110681
P407
P577
2014-10-14T00:00:00Z